Inventor · disambiguated record
Makoto Kamata
Also filed as: KAMATA MAKOTO
38 granted patents·13 pending applications·124 citations·filing 2002–2024
97Inventor score
Files withTAKEDA PHARMACEUTICALS CO35TAKEDA PHARMACEUTICAL10KOIKE TATSUKI2TANIGUCHI TAKAHIKO2KAMATA MAKOTO1
Top patents by PatentIndex Score
51 records- 0195US9878989B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jan 30, 2018·7 cites·2 claims
- 0294US9518042B2Nitrogen-containing heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Dec 13, 2016·8 cites·2 claims
- 0394US9499516B2Nitrogen-containing heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Nov 22, 2016·8 cites·2 claims
- 0494US9315458B2Nitrogen-containing heterocyclic compoundTAKEDA PHARMACEUTICAL·Filed 2015·Granted Apr 19, 2016·8 cites·2 claims
- 0593US10087150B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Oct 2, 2018·5 cites·2 claims
- 0692US10428056B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Oct 1, 2019·4 cites·2 claims
- 0791US10548899B2Quinazolinone and benzotriazinone compounds with cholinergic muscarinin M1 receptor positive allosteric modulator activityTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Feb 4, 2020·7 cites·11 claims
- 0891US9868725B2Isoindoline-1-one derivatives as cholinergic muscarinic M1 receptor positive alloesteric modulator activity for the treatment of Alzheimer's diseaseTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Jan 16, 2018·5 cites·16 claims
- 0990US10323027B22,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptorTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jun 18, 2019·4 cites·6 claims
- 1090US2024109874A1Nitrogen-containing heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 1189US10807987B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Oct 20, 2020·5 cites·8 claims
- 1286US10457670B2Isoindoline-1-one derivatives as cholinergic muscarinic M1 receptor positive alloesteric modulator activity for the treatment of Alzheimers diseaseTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Oct 29, 2019·2 cites·13 claims
- 1386US10106556B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Oct 23, 2018·8 cites·20 claims
- 1486US9789084B2Nitrogen-containing heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Oct 17, 2017·2 cites·5 claims
- 1586US9789083B2Nitrogen-containing heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Oct 17, 2017·2 cites·5 claims
- 1686US9775827B2Nitrogen-containing heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Oct 3, 2017·2 cites·5 claims
- 1786US9675597B2Nitrogen-containing heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jun 13, 2017·2 cites·1 claims
- 1886US9662316B2Nitrogen-containing heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted May 30, 2017·2 cites·1 claims
- 1986US9655881B2Nitrogen-containing heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted May 23, 2017·2 cites·1 claims
- 2085US10899752B22,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptorTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Jan 26, 2021·1 cites·11 claims
- 2184US11702419B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Jul 18, 2023·1 cites·18 claims
- 2284US2022411413A1Nitrogen-containing heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 2382US10208046B2Nitrogen-containing heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Feb 19, 2019·4 cites·14 claims
- 2481US9777005B2Bicyclic heterocyclic compound containing a substituted pyrrole ringTAKEDA PHARMACEUTICALS CO·Filed 2013·Granted Oct 3, 2017·5 cites·12 claims
- 2580US11827601B2Heterocyclic NMDA antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Nov 28, 2023·0 cites·8 claims
- 2680US11274101B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Mar 15, 2022·1 cites·12 claims
- 2778US11834409B2Heterocyclic NMDA antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Dec 5, 2023·0 cites·22 claims
- 2878US8563575B2Fused heterocyclic compoundsTANIGUCHI TAKAHIKO·Filed 2011·Granted Oct 22, 2013·4 cites·15 claims
- 2976US10865200B2Nitrogen-containing heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Dec 15, 2020·0 cites·3 claims
- 3076US7601868B2Amine derivativeTAKEDA PHARMACEUTICAL·Filed 2004·Granted Oct 13, 2009·8 cites·21 claims
- 3176US2021009572A1Nitrogen-containing heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2020·Application pending·0 cites
- 3275US8940758B2Fused heterocyclic compoundsTAKEDA PHARMACEUTICAL·Filed 2013·Granted Jan 27, 2015·2 cites·17 claims
- 3375US8846713B2Fused heterocyclic compounds as phosphodiesterases (PDEs) inhibitorsTANIGUCHI TAKAHIKO·Filed 2011·Granted Sep 30, 2014·2 cites·2 claims
- 3474US9226921B2Fused heterocyclic compounds as phosphodiesterases (PDES) inhibitorsTAKEDA PHARMACEUTICAL·Filed 2014·Granted Jan 5, 2016·2 cites·17 claims
- 3572US8501804B2Bicyclic compoundKAMATA MAKOTO·Filed 2009·Granted Aug 6, 2013·6 cites·9 claims
- 3670US7183415B2Quinoline compoundTAKEDA PHARMACEUTICAL·Filed 2002·Granted Feb 27, 2007·5 cites·15 claims
- 3769US2018000780A1Nitrogen-containing heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2017·Application pending·0 cites
- 3864US2023002318A1Heterocyclic nmda antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2020·Application pending·0 cites
- 3963US2024309016A1Macrocyclic heterocycle compounds and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 4062US2024217957A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 4157US2014350260A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICAL·Filed 2014·Application pending·0 cites
- 4254US8901309B2Fused triazoles for the treatment or prophylaxis of mild cognitive impairmentKOIKE TATSUKI·Filed 2011·Granted Dec 2, 2014·0 cites·1 claims
- 4352US11952344B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Apr 9, 2024·0 cites·5 claims
- 4452US8822699B2Heterocyclic compound and use thereofKOIKE TATSUKI·Filed 2011·Granted Sep 2, 2014·0 cites·6 claims
- 4547US2010113418A1Heterocyclic compoundTAKEDA PHARMACEUTICAL·Filed 2008·Application pending·0 cites
- 4646US10131653B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Nov 20, 2018·0 cites·12 claims
- 4746US2010093777A1Spiro-ring compoundTAKEDA PHARMACEUTICAL·Filed 2008·Application pending·0 cites
- 4845US2009281097A1Nitrogen-containing heterocyclic compoundTAKEDA PHARMACEUTICAL·Filed 2007·Application pending·0 cites
- 4943US2022089525A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2020·Application pending·0 cites
- 5042US2010160255A1Spiro-cyclic compoundTAKEDA PHARMACEUTICAL·Filed 2006·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Makoto Kamata files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →